167 related articles for article (PubMed ID: 17994459)
1. Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats.
Tofovic SP; Salah EM; Jackson EK; Melhem M
Ren Fail; 2007; 29(7):891-902. PubMed ID: 17994459
[TBL] [Abstract][Full Text] [Related]
2. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
Rafikova O; Salah EM; Tofovic SP
Metabolism; 2008 Oct; 57(10):1434-44. PubMed ID: 18803950
[TBL] [Abstract][Full Text] [Related]
3. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.
Bilan VP; Salah EM; Bastacky S; Jones HB; Mayers RM; Zinker B; Poucher SM; Tofovic SP
J Endocrinol; 2011 Sep; 210(3):293-308. PubMed ID: 21680617
[TBL] [Abstract][Full Text] [Related]
4. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats.
Tofovic SP; Kost CK; Jackson EK; Bastacky SI
Kidney Int; 2002 Apr; 61(4):1433-44. PubMed ID: 11918750
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats.
Zhang X; Jia Y; Jackson EK; Tofovic SP
J Cardiovasc Pharmacol; 2007 Jan; 49(1):56-63. PubMed ID: 17261964
[TBL] [Abstract][Full Text] [Related]
6. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of the superoxide dismutase mimetic tempol on split kidney function in two-kidney one-clip hypertensive rats.
Guron GS; Grimberg ES; Basu S; Herlitz H
J Hypertens; 2006 Feb; 24(2):387-94. PubMed ID: 16508588
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
9. 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.
Tofovic SP; Dubey RK; Jackson EK
J Pharmacol Exp Ther; 2001 Dec; 299(3):973-7. PubMed ID: 11714885
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
11. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
13. Renal and metabolic effects of caffeine in obese (fa/fa(cp)), diabetic, hypertensive ZSF1 rats.
Tofovic SP; Kusaka H; Jackson EK; Bastacky SI
Ren Fail; 2001 Mar; 23(2):159-73. PubMed ID: 11417948
[TBL] [Abstract][Full Text] [Related]
14. Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes.
Griffin KA; Abu-Naser M; Abu-Amarah I; Picken M; Williamson GA; Bidani AK
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1605-13. PubMed ID: 17728379
[TBL] [Abstract][Full Text] [Related]
15. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
[TBL] [Abstract][Full Text] [Related]
16. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
[TBL] [Abstract][Full Text] [Related]
17. Renal disease in obesity: the need for greater attention.
Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
[TBL] [Abstract][Full Text] [Related]
18. Double-edged action of SOD mimetic in diabetic nephropathy.
Asaba K; Tojo A; Onozato ML; Goto A; Fujita T
J Cardiovasc Pharmacol; 2007 Jan; 49(1):13-9. PubMed ID: 17261958
[TBL] [Abstract][Full Text] [Related]
19. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
